Table 5

Epistatic effects with BF ≥ 1 in analyzing the BM2 data.

Markers

Coefficient

S.D.

BF

(1–3.6, 3–14.34)

0.0601

0.1077

1.36

(1–3.6, 3–101.29)

0.0383

0.0994

1.05

(1–14.2, 2–28.53)

0.0156

0.0792

1.07

(1–14.2, 3–134.6)

0.2231

0.1552

116.30

(1–14.2, 3–139)

0.1689

0.1453

13.40

(2–17.08, 3–157.73)

0.3304

0.0806

> 1000

(2–28.53, 3–101.29)

0.2688

0.1063

> 1000

(2–34.72, 3–76.3)

0.1307

0.0960

5.34

(2–113.92, 3–83.15)

0.0779

0.0911

1.89

(2–138.82, 3–147.69)

0.1678

0.0943

12.23

(2–143, 3–101.29)

0.0463

0.0972

1.25

(2–145.85, 3–28.74)

0.0896

0.0909

2.61

(2–145.85, 3–43.2)

0.0330

0.0980

1.07

(2–145.85, 3–101.29)

0.0419

0.0921

1.29

(3–21.3, 3–76.3)

0.0797

0.0856

1.97

(3–28.74, 3–53.54)

0.0487

0.0999

1.19

(3–43.2, 3–123.32)

0.0400

0.1014

1.04

(3–53.54, 3–123.33)

0.1925

0.1226

43.36

The QTL positions of each significant epistatic effect are specified by the indices of the corresponding chromosomes and the locations on the chromosomes (cM). The estimated sizes of the epistatic effects and the standard deviations of the Markov chains are also shown in the columns of coefficient and S.D., respectively.

Zhang et al. BMC Bioinformatics 2008 9:251   doi:10.1186/1471-2105-9-251